- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/94 - Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
Patent holdings for IPC class C07D 233/94
Total number of patents in this class: 36
10-year publication summary
|
1
|
3
|
2
|
9
|
4
|
2
|
1
|
3
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Evofem Biosciences, Inc. | 50 |
15 |
| Galderma Research & Development | 371 |
3 |
| Theaprin Pharmaceuticals Inc. | 32 |
2 |
| Sanofi | 4243 |
2 |
| Merck Patent GmbH | 5668 |
1 |
| The Johns Hopkins University | 5825 |
1 |
| Auckland UniServices Limited | 499 |
1 |
| China Pharmaceutical University | 349 |
1 |
| Fudan University | 742 |
1 |
| National University Corporation Hokkaido University | 1350 |
1 |
| Nihon Medi-physics Co., Ltd. | 177 |
1 |
| Symbiomix Therapeutics, LLC | 3 |
1 |
| Technische Universitat Munchen | 707 |
1 |
| Lupin Inc. | 66 |
1 |
| Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd. | 59 |
1 |
| Merck Sharp & Dohme LLC | 3729 |
1 |
| Anpel Laboratory Technologies (Shanghai) Inc. | 11 |
1 |
| Technische Universität München, in Vertretung des Freistaates Bayern | 46 |
1 |
| Other owners | 0 |